In todays episode we have updates for your from the FDA on approval of Uplizna for NMOSD, Zepzelca for metastatic small cell lung cancer, and new indications for Tivicay and Ilaris. Don't forget to like, share, and subscribe - Enjoy!
In todays episode we have updates for your from the FDA on approval of Uplizna for NMOSD, Zepzelca for metastatic small cell lung cancer, and new indications for Tivicay and Ilaris. Don't forget to like, share, and subscribe - Enjoy!